BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8431913)

  • 1. Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia.
    Amiel A; Yarkoni S; Fejgin M; Gaber E; Nagler A; Manor Y; Lishner M
    Cancer Genet Cytogenet; 1993 Jan; 65(1):32-4. PubMed ID: 8431913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection.
    Garcia-Isidoro M; Tabernero MD; Garcia JL; Najera ML; Hernandez JM; Wiegant J; Raap A; San Miguel J; Orfao A
    Hum Pathol; 1997 Feb; 28(2):154-9. PubMed ID: 9023395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
    Acar H; Stewart J; Connor MJ
    Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.
    Dewald GW; Wyatt WA; Juneau AL; Carlson RO; Zinsmeister AR; Jalal SM; Spurbeck JL; Silver RT
    Blood; 1998 May; 91(9):3357-65. PubMed ID: 9558393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization.
    Tkachuk DC; Westbrook CA; Andreeff M; Donlon TA; Cleary ML; Suryanarayan K; Homge M; Redner A; Gray J; Pinkel D
    Science; 1990 Oct; 250(4980):559-62. PubMed ID: 2237408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques.
    Fugazza G; Bruzzone R; Dejana AM; Patrone F; Sessarego M
    Cancer Genet Cytogenet; 1994 Jan; 72(1):24-7. PubMed ID: 8111734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
    Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
    Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].
    Kim MK; Mun YC; Seong CM; Chung WS; Huh J
    Korean J Lab Med; 2010 Dec; 30(6):711-7. PubMed ID: 21157160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of variant translocations in chronic myeloid leukemia by fluorescence in situ hybridization.
    Acar H; Stewart J; Boyd E; Connor MJ
    Cancer Genet Cytogenet; 1997 Feb; 93(2):115-8. PubMed ID: 9078295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization.
    Seong DC; Liu P; Siciliano J; Zhao Y; Cork A; Henske E; Warburton D; Yu MT; Champlin R; Trujillo JM
    Cancer Genet Cytogenet; 1993 Feb; 65(2):100-3. PubMed ID: 8453592
    [No Abstract]   [Full Text] [Related]  

  • 14. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia.
    Costa D; Espinet B; Queralt R; Carrió A; Solé F; Colomer D; Cervantes F; Hernández JA; Besses C; Campo E
    Cancer Genet Cytogenet; 2003 Mar; 141(2):114-9. PubMed ID: 12606128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.